Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is stunning prevented by ischemic preconditioning?

S M Mosca1, R J Gelpi, J Milei

  • 1Centro de Investigaciones Cardiovasculares Universidad Nacional de La Plata, Argentina.

Molecular and Cellular Biochemistry
|October 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Middle-age abolishes cardioprotection conferred by thioredoxin-1 in mice.

Archives of biochemistry and biophysics·2024
Same author

Left ventricular hypertrophy does not prevent heart failure in experimental hypertension.

International journal of cardiology·2017
Same author

Plasma Enalapril Kinetics of Two Modified Formulations Tested in Healthy Volunteers. A Pilot Trial Searching for an Optimum Blood Pressure Control.

Journal of the American Society of Hypertension : JASH·2016
Same author

Ozonetherapy protects from in-stent coronary neointimal proliferation. Role of redoxins.

International journal of cardiology·2016
Same author

Relation between periodontal disease and arterial stiffness.

Journal of periodontal research·2016
Same author

Lithotomy's prohibition and referral to experts in medical oaths of hippocratic stemma.

Actas urologicas espanolas·2016

Ischemic preconditioning protects rat hearts from contractile dysfunction following global ischemia and reperfusion. This method significantly improves cardiac function recovery and reduces stunning effects.

Area of Science:

  • Cardiology
  • Physiology
  • Pathology

Background:

  • Global ischemia and reperfusion cause significant cardiac contractile dysfunction, known as stunning.
  • Assessing myocardial stunning involves measuring left ventricular developed pressure (LVDP) and its maximal rate of increase (+dP/dtmax).
  • Necrotic area assessment using triphenyltetrazхимиcal chloride (TTC) and immunohistochemistry are key diagnostic tools.

Purpose of the Study:

  • To investigate the protective effects of ischemic preconditioning on cardiac function after global ischemia.
  • To evaluate the efficacy of modified reperfusion solutions in mitigating ischemia-reperfusion injury.
  • To determine if ischemic preconditioning enhances the heart's response to inotropic interventions.

Main Methods:

  • Global ischemia (20 min) followed by reperfusion (30 min) in isolated perfused rat hearts.

Related Experiment Videos

  • Measurement of left ventricular developed pressure (LVDP) and +dP/dtmax to assess contractile function.
  • Immunohistochemistry and TTC staining to evaluate myocardial damage and necrosis.

    • Main Results:

    • Ischemia-reperfusion significantly reduced LVDP and +dP/dtmax, increasing left ventricular end-diastolic pressure (LVEDP).
    • Ischemic preconditioning preserved contractile function, stabilizing LVDP and +dP/dtmax at higher levels.
    • Early reperfusion with low Ca2+-low pH perfusate also protected contractile function, with lower LVEDP.

    Conclusions:

    • Ischemic preconditioning effectively diminishes contractile dysfunction associated with early myocardial stunning.
    • Modified reperfusion strategies offer protection against ischemia-reperfusion injury.
    • Ischemic preconditioning enhances the heart's maximal inotropic response post-insult.